Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The relationship between dose and serotonin transporter occupancy of antidepressants—a systematic review
Anders Sørensen, Henricus G. Ruhé, Klaus Munkholm
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 192-201
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis
Jonathan Henssler, Yannick Schmidt, Urszula Schmidt, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 7, pp. 526-535
Closed Access | Times Cited: 26
Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial
Annette Johansen, Sophia Armand, Pontus Plavén‐Sigray, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4272-4279
Open Access | Times Cited: 22
Natural kapok fiber as a green and efficient adsorbent for in-syringe solid-phase extraction in the determination of antidepressants in biofluids
Yu-Mei Gan, Linlin Hua, Yuanyuan Zheng, et al.
Microchemical Journal (2024) Vol. 201, pp. 110638-110638
Closed Access | Times Cited: 8
Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review
Mi-Mi Zhang, Xuan Tan, Yongbo Zheng, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 6
Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review
Anders Sørensen, Karsten Juhl Jørgensen, Klaus Munkholm
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 28
Withdrawing from SSRI antidepressants: advice for primary care
Emilia G. Palmer, Sangeetha Sornalingam, Lisa Page, et al.
British Journal of General Practice (2023) Vol. 73, Iss. 728, pp. 138-140
Open Access | Times Cited: 13
Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder
Michael Cronquist Christensen, Roger S. McIntyre, Michael Adair, et al.
CNS Spectrums (2023) Vol. 28, Iss. 6, pp. 693-701
Open Access | Times Cited: 12
Photodegradation of psychotropic medications: Impact on efficacy, safety, and drug properties
Ana-Maria Udrea, Cătălin Buiu, Angela Staicu, et al.
Computers in Biology and Medicine (2025) Vol. 191, pp. 110115-110115
Open Access
Simplified methods for SERT occupancy estimation measured with [11C]DASB PET bolus plus infusion
Magdalena Ponce de León, Matej Murgaš, Leo R. Silberbauer, et al.
NeuroImage (2025), pp. 121208-121208
Open Access
The Association of Antidepressants in Late Pregnancy with Postpartum Hemorrhage: Systematic Review of Controlled Observational Studies
William V. Bobo, Katherine M. Moore, Hannah K. Betcher, et al.
Journal of Child and Adolescent Psychopharmacology (2024) Vol. 34, Iss. 10, pp. 428-446
Closed Access | Times Cited: 3
Modulation of autism-associated serotonin transporters by palmitoylation: Insights into the molecular pathogenesis and targeted therapies for autism spectrum disorder
Christopher R. Brown, James D. Foster
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Glutamatergic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using magnetic resonance spectroscopy: A controlled study
Eliška Nosková, Dita Pajuelo, David Greguš, et al.
Psychiatry Research Neuroimaging (2023) Vol. 335, pp. 111721-111721
Closed Access | Times Cited: 8
‘We need more support and doctors that understand the process of tapering …’: A content analysis of free‐text responses to a questionnaire on discontinuing long‐term benzodiazepine receptor agonist use
Thomas R. Lynch, Cristín Ryan, Christy Huff, et al.
Health Expectations (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 2
Allosteric modulation of serotonin and dopamine transporters: New insights from computations and experiments
Hoang Linh Nguyen, Mary Hongying Cheng, Ji Young Lee, et al.
Current Research in Physiology (2024) Vol. 7, pp. 100125-100125
Open Access | Times Cited: 2
Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Renjie Gao, Panpan Zhao, Kai Yan
Clinical Drug Investigation (2024) Vol. 44, Iss. 7, pp. 459-469
Closed Access | Times Cited: 2
Absetzen von Antidepressiva – Absetzsymptome und Rebound-Effekte
Tom Bschor, Udo Bonnet, Martina Pitzer, et al.
Der Nervenarzt (2022) Vol. 93, Iss. 1, pp. 93-101
Closed Access | Times Cited: 9
Future Prospects of Positron Emission Tomography–Magnetic Resonance Imaging Hybrid Systems and Applications in Psychiatric Disorders
Young‐Don Son, Young-Bo Kim, Jong‐Hoon Kim, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 583-583
Open Access | Times Cited: 9
An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist
Amy McGoldrick, Helen M. Byrne, Cathal Cadogan
International Journal of Clinical Pharmacy (2023) Vol. 45, Iss. 5, pp. 1074-1087
Open Access | Times Cited: 5
Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: systematic review of reviews and meta-narrative synthesis
Chris Johnson, Margaret Maxwell, Brian Williams, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000017-e000017
Open Access | Times Cited: 8
Rethinking the medication management of major depression
J. John Mann, Mina Rizk
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 4, pp. 331-363
Closed Access | Times Cited: 4
Evaluating lumateperone for its use in treating depressive episodes associated with bipolar I or II disorder in adults
Hagar Abuelazm, Omar H. Elsayed, Rif S. El‐Mallakh
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 8, pp. 751-756
Closed Access | Times Cited: 4
ABCB1 variants and sex affect serotonin transporter occupancy in the brain
Leo R. Silberbauer, Lucas Rischka, Chrysoula Vraka, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 11, pp. 4502-4509
Open Access | Times Cited: 6
Systematic review of studies using platelet serotonin content to assess bioeffect of serotonin reuptake inhibitors at the serotonin transporter
George M. Anderson, Isabella Bruno-Pacella
Psychopharmacology (2022) Vol. 240, Iss. 1, pp. 1-13
Closed Access | Times Cited: 6
Interventions to help patients withdraw from depression drugs: A systematic review
Peter C Gøtzsche, Maryanne Demasi
International Journal of Risk & Safety in Medicine (2023) Vol. 35, Iss. 2, pp. 103-116
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top